CMS develops platform drug delivery technologies to optimize every active ingredient used to improve the entire experience of administering a therapeutic product. We utilize innovative and novel methods and extensive research and development to create products that are more efficacious and stable than products using other traditional delivery systems. Our patented and proprietary drug delivery systems provide solutions for superior quality, enhanced patient compliance, maximum active ingredient load potential, and the integration of diverse flavor masking methods.
Our platform delivery systems, whether ingestible, sublingual, topical, or transdermal are designed for the optimization of the active ingredients and the best user experience. CMS has legacy proven technology that loads the highest levels of active ingredients in the industry. The versatile formulations provide a foundation for a wide variety of applications and innovative products.
The CMS oral thin film platform continues to advance through our constant research and development. We are currently developing new and exciting technologies, including: binding system to facilitate improved encapsulation methods, modification of dissolution rates and properties, creating broader potential of flavor systems, and optimizing bioavailability and absorption through controlled and sustained release methods.
As our drug delivery systems evolve, it is CMS’s continuing strategy to push the envelope of what products are possible while also increasing productivity and manufacturing potential.
CMS develops platform drug delivery technologies to optimize every active ingredient used to improve the entire experience of administering a therapeutic product. We utilize innovative and novel methods and extensive research and development to create products that are more efficacious and stable than products using other traditional delivery systems. Our patented and proprietary drug delivery systems provide solutions for superior quality, enhanced patient compliance, maximum active ingredient load potential, and the integration of diverse flavor masking methods.
Our platform delivery systems, whether ingestible, sublingual, topical, or transdermal are designed for the optimization of the active ingredients and the best user experience. CMS has legacy proven technology that loads the highest levels of active ingredients in the industry. The versatile formulations provide a foundation for a wide variety of applications and innovative products.
The CMS oral thin film platform continues to advance through our constant research and development. We are currently developing new and exciting technologies, including: binding system to facilitate improved encapsulation methods, modification of dissolution rates and properties, creating broader potential of flavor systems, and optimizing bioavailability and absorption through controlled and sustained release methods.
As our drug delivery systems evolve, it is CMS’s continuing strategy to push the envelope of what products are possible, while also increasing productivity and manufacturing potential.